Novartis goes after Roche asthma medicine Xolair with new drug

Novartis said it is pushing ahead with a late-stage study of its experimental drug ligelizumab after announcing the medicine outperformed Roche's Xolair in a Phase II clinical trial against urticaria, also known as hives.

from Reuters: Health News https://ift.tt/2E9JASp
via IFTTT